The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksB&M Regulatory News (BME)

Share Price Information for B&M (BME)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 548.20
Bid: 546.40
Ask: 546.60
Change: 13.20 (2.47%)
Spread: 0.20 (0.037%)
Open: 536.60
High: 548.20
Low: 536.20
Prev. Close: 535.00
BME Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AGM Voting Results

29 Jul 2022 10:28

RNS Number : 2590U
B&M European Value Retail S.A.
29 July 2022
 

 

 

29 July 2022

B&M European Value Retail S.A.

 

 

AGM Voting Results

 

 

All resolutions proposed at the Annual General Meeting of the Company held on 28 July 2022 were passed on a poll by shareholders. The results of the poll were as follows.

 

VOTES

FOR

%

VOTES

AGAINST

%

VOTES

TOTAL

% of ISC

VOTED

VOTES WITHHELD

1

To receive the Directors Report on the Annual Accounts of the Company for the year ended March 2022

 

690,135,303

99.8

1,613,795

0.2

691,749,098

69.09

1,769,229

2

To receive the consolidated and unconsolidated Financial Statements and Annual Accounts for the financial year ended March 2022 and the Auditor's Reports thereon

 

690,135,303

99.8

1,613,795

0.2

691,749,098

69.09

1,769,229

3

To approve the consolidated Financial Statements and Annual Accounts of the Company for the year ended 26 March 2022

690,135,303

99.8

1,613,795

0.2

691,749,098

69.09

1,769,229

4

To approve the unconsolidated Financial Statements and Annual Accounts of the Company for the year ended 31 March 2022

 

690,134,972

99.8

1,614,126

0.2

691,749,098

69.09

1,769,229

5

To approve the result of the Company for the year ended 31 March 2022 and allocation

 

692,447,944

100

0

0.0

692,447,944

69.16

1,070,383

6

To approve the total dividend of the Company for the year ended 31 March 2022

 

692,448,944

100

0

0.0

692,448,944

69.16

1,069,383

7

 

To receive and approve the annual report on the Directors' Remuneration

 

637,198,382

94.3

38,312,060

5.7

675,510,442

67.47

18,007,885

8

To discharge each of the Directors for the financial year ended 31 March 2022

 

687,806,873

99.5

3,355,234

0.5

691,062,107

69.03

2,356,220

9

To re-elect Peter Bamford as a Director

 

660,170,568

95.3

32,277,376

4.7

692,447,944

69.16

1,070,383

10

To re-elect Simon Arora as a Director

 

671,929,416

97.0

20,518,528

3.0

692,447,944

69.16

1,070,383

11

To re-elect Alejandro Russo as a Director

 

689,686,373

99.6

2,760,947

0.4

692,447,320

69.16

1,071,007

12

To re-elect Ron McMillan as a Director

 

584,930,361

86.5

91,350,493

13.5

676,280,854

67.55

17,237,473

13

To re-elect Tiffany Hall as a Director

 

638,580,013

92.2

53,867,207

7.8

692,447,220

69.16

1,071,107

14

To re-elect Carolyn Bradley as a Director

667,183,563

96.4

25,263,757

3.6

692,447,320

69.16

1,071,007

15

To re-elect Paula MacKenzie as a Director

692,096,400

99.9

351,544

0.1

692,447,944

69.16

1,070,383

16

To discharge the Independent Auditor for the year ended 31 March 2022

 

688,545,309

99.6

2,617,422

0.4

691,162,731

69.03

2,355,596

17

To re-appoint KPMG Luxembourg Société Coopérative as Independent Auditor of the Company

 

677,254,487

98.0

13,579,622

2.0

690,834,149

68.99

2,684,178

18

 

 

 

To authorise the Directors to determine the Independent Auditor's remuneration

678,868,282

98.0

13,579,622

2.0

692,447,944

69.16

1,070,383

19

To authorise the Company to make market purchases of its ordinary shares of up to 10% of its ordinary issued shares *

 

688,778,366

99.5

3,338,993

0.5

692,117,359

69.13

1,400,968

20

To confirm the Board of Directors have full power to issue ordinary shares on a non-pre-emptive basis for cash representing 5% of the issued share capital of the Company generally, as provided by the Articles of Association and to acknowledge the Directors' intention to comply with the Statement of Principles on Dis-applying Pre-Emption Rights to the extent practical for a Luxembourg company

 

692,296,618

99.98

152,326

0.02

692,448,944

69.16

1,069,383

21

To confirm the Board of Directors have full power, in addition to any authority granted under resolution 20, to issue ordinary shares on a non-pre-emptive basis, for cash representing a further 5% of the issued share capital of the Company for the purposes of financing an acquisition or a capital investment (or refinancing such a transaction) as defined in the Statement of Principles on Dis-Applying Pre-Emption Rights, as provided by the Articles of Association

 

690,606,503

99.7

1,781,172

0.3

692,387,675

69.15

1,130,652

 

* Whilst the Company seeks authority on an annual basis to perform share buybacks (as is customary for UK PLCs), the Board notes that it has no current intention of utilising this authority, reflecting the complexities of executing an on market buyback for a company incorporated in Luxembourg such as B&M. The Board continuously reviews the Group's capital structure and has regularly returned funds to all its shareholders by way of both ordinary and special dividends.

 

 

The results of the poll will also be posted on the Company's website at www.bandmretail.com

 

Please note that a vote withheld is not a vote in law and is not counted in the calculation of votes for and against a resolution.

 

The total number of shares of the Company in issue on the record date on 14 July 2022 (for being eligible to vote at the AGM) was 1,001,226,836 ordinary shares.

 

 

Enquiries

 

B&M European Value Retail S.A.

For further information please contact +44 (0) 151 728 5400

Simon Arora, Chief Executive Officer

Alejandro Russo, Chief Financial Officer

Investor.relations@bandmretail.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ROMRLMLTMTTTMJT
Date   Source Headline
18th Jan 202211:11 amRNSHolding(s) in Company
18th Jan 202211:01 amRNSDirector/PDMR Shareholding
14th Jan 20227:00 amRNSResult of Secondary Placing of Ordinary Shares
13th Jan 20224:45 pmRNSProposed Secondary Placing of Ordinary Shares
13th Jan 20221:05 pmRNSBlock listing Interim Review
6th Jan 20227:00 amRNSQ3 FY22 Trading Update
30th Dec 20214:58 pmRNSPost Stabilisation Notice
9th Dec 20217:00 amRNSSpecial Dividend
24th Nov 202111:02 amRNSDirector/PDMR Notice
17th Nov 20213:48 pmRNSPricing of Senior Secured Notes Offering
15th Nov 20218:16 amRNSLaunch of Senior Secured Notes Offering
11th Nov 20217:00 amRNSFY22 Interim Results
10th Nov 20214:19 pmRNSHolding(s) in Company
10th Nov 202111:42 amRNSResult of Ordinary General Meeting
30th Sep 20219:00 amRNSTotal Voting Rights
30th Sep 20219:00 amRNSOrdinary General Meeting
16th Sep 20219:26 amRNSDirector/PDMR Shareholding
8th Sep 20219:36 amRNSTrading Update
12th Aug 20217:00 amRNSBoard Appointment
4th Aug 20218:00 amRNSBlock Listing Application
3rd Aug 202111:12 amRNSDirector/PDMR Shareholding
2nd Aug 202110:32 amRNSTotal Voting Rights
29th Jul 202112:16 pmRNSResult of AGM
20th Jul 202112:35 pmRNSDirector Declaration
16th Jul 20218:00 amRNSDirector/PDMR Shareholding
14th Jul 202111:22 amRNSDirector/PDMR Shareholding
13th Jul 20219:00 amRNSBlock listing Interim Review
8th Jul 20217:00 amRNSTrading Statement
21st Jun 20217:00 amRNSAnnual Financial Report
3rd Jun 20217:00 amRNSBoard Change
3rd Jun 20217:00 amRNSPreliminary Results
15th Mar 202110:16 amRNSHolding(s) in Company
4th Mar 20217:00 amRNSTrading Update
1st Mar 20219:48 amRNSTotal Voting Rights
25th Feb 20219:20 amRNSDirector Declaration
22nd Feb 20215:06 pmRNSDirector/PDMR Securities
10th Feb 20212:16 pmRNSHolding(s) in Company
9th Feb 202110:05 amRNSHolding(s) in Company
27th Jan 20217:00 amRNSHolding(s) in Company
20th Jan 20213:17 pmRNSHolding(s) in Company
20th Jan 202111:02 amRNSHolding(s) in Company
15th Jan 20214:02 pmRNSHolding(s) in Company
14th Jan 202112:52 pmRNSDirector/PDMR Shareholding
13th Jan 20219:24 amRNSBlock listing Interim Review
12th Jan 202110:00 amRNSDirector Declaration
12th Jan 20217:00 amRNSResults of Placing
11th Jan 20215:22 pmRNSProposed Secondary Placing
7th Jan 20217:00 amRNSTrading Statement
29th Dec 20209:25 amRNSDirector/PDMR Securities
29th Dec 20209:18 amRNSDirector/PDMR Securities

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.